2023专家共识声明：注意力缺陷_多动障碍和物质使用障碍患者的识别和治疗.docx

《2023专家共识声明：注意力缺陷_多动障碍和物质使用障碍患者的识别和治疗.docx》由会员分享，可在线阅读，更多相关《2023专家共识声明：注意力缺陷_多动障碍和物质使用障碍患者的识别和治疗.docx（74页珍藏版）》请在第一文库网上搜索。

1、Name of Journal: World Journal OfPsychiatryManuscript NO: 81739Manuscript Type: EXPERT CONSENSUSIdentification and treatment of individuals with attention-deficihyperactivity disorder and substance use disorder: An expert consensus statementYoung S et al. Consensus statement: ADHD and SUDSusan Young

2、, Cyrus Abbasian, Zainab Al-Attarz Polly Branney, Bill Colley, Samuele Cortesez Sally Cubbin, Quinton Deeley, Gisli Hannes Gudjonsson, Peter Hillz Jack Hollingdale, Steve Jenden, Joe Johnson, Deborah Judge, Alexandra Lewis, Peter Mason, Raja Mukherjee, David Nuttz Jane Roberts, Fiona Robinson, Emma

3、Woodhouse, Kelly CocallisSusan Youngz Department of Psychology, Psychology Services Limited, Croydon CR9 7AEz United KingdomSusan Young, Department of Psychology, Reykjavik University, Reykjavik, IcelandCyrus Abbasian, Zainab Al-Attarz Psychiatry-UK Limited, Cornwall PL33 9ET, United KingdomPolly Br

4、anney, ADHD and Autism, Oxford ADHD & Autism Centre, Headington 0X3 7BXz United KingdomBill Colleyz CLC Consultancy, Dunkeld PH8 OAYz United KingdomSamuele Cortesez Center for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, So

5、uthampton SOl71BJ, United KingdomSally Cubbin, Adult ADHD, Adult ADHD Clinic Ltd, Oxford 0X3 7RP, United KingdomQuinton Deeley, Forensic and Neurodevelopmental Science, Institute of Psychiatry, Psychology & Neuroscience, Kings College London Institute of Psychiatry, London SE5 8AF, United KingdomGis

6、li Hannes Gudjonssonz Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, London SE5 8AF, United KingdomPeter Hill, Department of Psychiatry, University Of London, London WClE 7HUz United KingdomJack Hollingdalez Department of Psychology, Compass Psych

7、ology Services Ltd, London BRl 9DX, United KingdomSteve Jendenz Deborah Judge, Birribi Ltd, Narberth SA67 7DU, United KingdomJoe Johnson, Halton and Knowsley Adult ADHD Team, Merseycare NHS Foundation Trust, Winwick WA2 9WA, United KingdomAlexandra Lewis, Department of Psychiatry, Fulbourn Hospital,

8、 Cambridge CB21 5EF, United KingdomPeter Mason, Department of Psychiatry, Dr Peter Mason ADHD & Psychiatry Services Limited, Liverpool Ll 9AR, United KingdomRaja Mukherjeez Adult Neurodevelopmental Service, Horizon House, Epsom KTl7 4QJz United KingdomDavid Nutt, Department of Psychiatry, Imperial C

9、ollege London, London WSl2 ONN, United KingdomJane Roberts, Service User Representative, Gloucestershire GLl 3NN, United KingdomFiona Robinson, Drug & Alcohol Services, Surrey & Borders Partnership Trust, Leatherhead KT22 7AD, United KingdomEmma Woodhouse, Forensic and Neurodevelopmental Sciences, I

10、nstitute of Psychiatry, Psychology & Neuroscience, Kings College London, London SE5 8AF, United KingdomKelly Cocallisz Wansbeck General Hospital, Northumbria Healthcare NHS Foundation Trust, Ashington NE63 9JJ, United KingdomAuthor contributions: Young S was responsible for the planning and scientif

11、ic input of this consensus statement; all authors attended the consensus meeting; Cocallis K completed the first draft of the manuscript; It was substantially revised by Young S with further input from Nutt D, Mason P and Mukherjee R; The second draft was revised and circulated by Young S and Cocall

12、is K to all authors for comment and endorsement of the consensus; Following further feedback and amendments by Young S and Cocallis K, the final draft was circulated once more; all authors have read and approved the final manuscript.Corresponding author: Susan Young, PhDz Professor, Department of Ps

13、ychology, Psychology Services Limited, PO 1735, Croydon CR9 7AE, United Kingdom. SUZyyoUngaol .comReceived: November 22, 2022Revised: February 19,2023Accepted: March 14, 2023Published online: March 19, 2023AbstractAttention-deficithyperactivity disorder (ADHD) often co-occurs with substance use (SU)

14、 and/or substance use disorder (SUD). Individuals with concurrent ADHD and SU/SUD can have complex presentations that may complicate diagnosis and treatment. This can be further complicated by the context in which services are delivered. Also, when working with young people and adults with co-existi

15、ng ADHD and SU/SUD, there is uncertainty among healthcare practitioners on how best to meet their needs. In February 2022z the United Kingdom ADHD Partnership hosted a meeting attended by multidisciplinary experts to address these issues. Following presentations providing attendees with an overview

16、of the literature, group discussions were held synthesizing research evidence and clinical experience. Topics included: (1) a review of substances and reasons for use/ misuse; (2) identification, assessment and treatment of illicit SU/SUD in young people and adults with ADHD presenting in community services; and (3) identification, assessment and treatment of ADHD in adults presenting in SU/SUD community and inpatient serv